Health & Wellness GSK acquires late-stage Canadian biopharma company BELLUS Health for USD$2B Approximately 28 million patients suffer from refractory chronic cough Joseph MortonApril 20, 2023
AI and Autonomy The Mugglehead technology roundup: sleep technologies Here's a bird's eye view of the sleep technology industry. Joseph MortonAugust 17, 2022